The 2009 figure included $4.6 million from sales of six of its RIO systems and $2.0 million from sales of its implants for 418 Makoplasty procedures.
The company markets the RIO Robotic-Arm Interactive Orthopedic system and Restoris implants for minimally invasive orthopedic knee procedures.
Read the release on Mako Surgical’s third-quarter earnings.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.